05:28 PM EST - Inflazyme Pharmaceuticals Ltd. : says its shareholders have voted overwhelmingly to approve the sale of the majority of its research and development assets to Biolipox AB, a Swedish drug company. The company said that 98 percent of shareholders voted in favor of the sale. Inflazyme Pharmaceuticals Ltd.
shares T.IZP are trading unchanged at $0.04.
